Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) have received an average broker rating score of 2.00 (Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.

Zacks has also given Innophos Holdings an industry rank of 63 out of 265 based on the ratings given to related companies.

Several research firms recently issued reports on IPHS. Zacks Investment Research lowered shares of Innophos Holdings from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 4th. KeyCorp reiterated a “hold” rating on shares of Innophos Holdings in a research report on Wednesday. Finally, BidaskClub lowered shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th.

Shares of Innophos Holdings (NASDAQ IPHS) traded down $0.72 during trading on Friday, hitting $45.32. 116,523 shares of the company’s stock traded hands, compared to its average volume of 99,104. Innophos Holdings has a 52 week low of $41.66 and a 52 week high of $58.22. The company has a market cap of $885.05, a PE ratio of 18.42 and a beta of 0.88. The company has a quick ratio of 1.73, a current ratio of 2.86 and a debt-to-equity ratio of 0.83.

Innophos Holdings (NASDAQ:IPHS) last announced its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.72 by $0.06. Innophos Holdings had a net margin of 6.19% and a return on equity of 13.90%. The firm had revenue of $184.00 million for the quarter, compared to analyst estimates of $179.33 million. During the same quarter in the prior year, the business posted $0.69 EPS. The business’s revenue was down 1.1% compared to the same quarter last year. research analysts forecast that Innophos Holdings will post 2.5 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Friday, November 17th will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $1.92 annualized dividend and a dividend yield of 4.24%. Innophos Holdings’s dividend payout ratio is 88.07%.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. boosted its position in shares of Innophos Holdings by 3.8% during the 2nd quarter. BlackRock Inc. now owns 2,432,009 shares of the specialty chemicals company’s stock worth $106,620,000 after acquiring an additional 89,360 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Innophos Holdings by 2.9% during the 2nd quarter. Vanguard Group Inc. now owns 1,926,577 shares of the specialty chemicals company’s stock worth $84,460,000 after acquiring an additional 54,505 shares in the last quarter. Daruma Capital Management LLC boosted its position in Innophos Holdings by 15.5% in the second quarter. Daruma Capital Management LLC now owns 1,182,095 shares of the specialty chemicals company’s stock valued at $51,823,000 after buying an additional 158,861 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Innophos Holdings by 0.4% in the second quarter. Dimensional Fund Advisors LP now owns 973,461 shares of the specialty chemicals company’s stock valued at $42,676,000 after buying an additional 3,717 shares in the last quarter. Finally, Frontier Capital Management Co. LLC boosted its position in Innophos Holdings by 1.5% in the third quarter. Frontier Capital Management Co. LLC now owns 869,238 shares of the specialty chemicals company’s stock valued at $42,758,000 after buying an additional 12,808 shares in the last quarter. Institutional investors and hedge funds own 94.43% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/04/brokerages-anticipate-innophos-holdings-inc-iphs-to-announce-0-56-eps.html.

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos Holdings (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.